Drug Res (Stuttg) 2017; 67(10): 557-563
DOI: 10.1055/s-0043-102692
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

New Biguanides as Anti-Diabetic Agents Part I: Synthesis and Evaluation of 1-Substituted Biguanide Derivatives as Anti-Diabetic Agents of Type II Diabetes Insulin Resistant

Samir Y. Abbas
1   Organometallic and Organometalloid Chemistry Department, National Research Centre, Cairo, Egypt
,
Wahid M. Basyouni
1   Organometallic and Organometalloid Chemistry Department, National Research Centre, Cairo, Egypt
,
Khairy A. M. El-Bayouk
1   Organometallic and Organometalloid Chemistry Department, National Research Centre, Cairo, Egypt
,
Wael M. Tohamy
1   Organometallic and Organometalloid Chemistry Department, National Research Centre, Cairo, Egypt
,
Hanan F. Aly
2   Therapeutic Chemistry Department, National Research Centre, Cairo, Egypt
,
Azza Arafa
2   Therapeutic Chemistry Department, National Research Centre, Cairo, Egypt
,
Mahmoud S. Soliman
2   Therapeutic Chemistry Department, National Research Centre, Cairo, Egypt
› Author Affiliations
Further Information

Publication History

Publication Date:
26 June 2017 (online)

Preview

Abstract

New 1-substituted-biguanide hydrochloride salts were synthesized via reacting benzo[1,3-d]dioxol-5-amine, phenylhydrazine, N,N-dimethylhydrazinecarboxamide, benzohydrazide and 2-phenyl acetohydrazide with dicyandiamide in acidic medium. Structures of the obtained biguanide salts were characterized by spectroscopic tools. The synthesized compounds were screened for their anti-diabetic activity with standard metformin drug. Oral treatment of hyperglycemic rats with the synthesized biguanide derivatives significantly decreased the elevated blood glucose level. Additionally, anti-diabetic properties towards liver function enzyme activities (AST, ALT and ALP), lipids profiles (TC, TG and TL), lipid peroxide and nitrous oxide as well as histopathological studies relative to metformin hydrochloride were investigated and discussed.

Supporting Information